Mortality, Neoplasia, and Creutzfeldt-Jakob Disease in Patients Treated With Human Pituitary Growth Hormone in the United Kingdom.

BMJ
doi 10.1136/bmj.302.6780.824
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Neurosurgery in a Patient With Creutzfeldt-Jakob Disease After Pituitary Derived Growth Hormone Therapy in Childhood.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1996English

Creutzfeldt-Jakob Disease After Pituitary Gonadotrophins.

BMJ
1993English

Short Report: Creutzfeldt-Jakob Disease Treated With Amantadine

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1979English

Creutzfeldt-Jakob Disease Mortality in Canada, 1998 to 2013

Canada Communicable Disease Report
2015English

Brain Biopsy in Patients With Suspected Creutzfeldt–Jakob Disease

Journal of Neurosurgery
SurgeryNeurology
2008English

Creutzfeldt–Jakob Disease

2015English

Geographic Difference of Mortality of Creutzfeldt-Jakob Disease in Japan

Journal of Epidemiology
MedicineEpidemiology
2007English

Creutzfeldt-Jakob Disease

The Lancet
Medicine
1996English

Creutzfeldt-Jakob Disease

The Lancet
Medicine
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy